Consun Pharmaceutical Group Limited (HKG:1681)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.58
+0.60 (3.53%)
Mar 10, 2026, 11:24 AM HKT
121.97%
Market Cap 14.29B
Revenue (ttm) 3.58B
Net Income (ttm) 1.11B
Shares Out 841.32M
EPS (ttm) 1.29
PE Ratio 13.16
Forward PE 10.78
Dividend 0.66 (4.05%)
Ex-Dividend Date n/a
Volume 2,048,000
Average Volume 1,788,976
Open 16.98
Previous Close 16.98
Day's Range 16.98 - 17.58
52-Week Range 7.76 - 19.49
Beta 0.57
RSI 45.53
Earnings Date Mar 26, 2026

About HKG:1681

Consun Pharmaceutical Group Limited researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China. It operates in two segments, Consun Pharmaceutical and Yulin Pharmaceutical. The company offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi particles for proteinuria; TCM to treat diabetic kidney disease; Gadopentetate Dimeglumine injections for nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function ass... [Read more]

Sector Healthcare
Founded 1997
Employees 3,073
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1681
Full Company Profile

Financial Performance

In 2024, HKG:1681's revenue was 2.97 billion, an increase of 14.56% compared to the previous year's 2.59 billion. Earnings were 910.46 million, an increase of 16.05%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.